Description
A competitive antagonist of farnesoid X receptor (IC50 = 17 µM ) that lowers LDL cholesterol and triglyceride levels in rodents fed a high cholesterol diet; demonstrates antitumor-promoting effects in human multiple myeloma and DU145 human prostate cancer cells